Privia Health Group’s (PRVA) Buy Rating Reiterated at Needham & Company LLC

Needham & Company LLC reissued their buy rating on shares of Privia Health Group (NASDAQ:PRVA) in a research note released on Friday morning,Benzinga reports. The firm currently has a $30.00 target price on the stock.

Several other research analysts have also recently weighed in on the stock. Stephens reiterated an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a research note on Thursday, January 2nd. JPMorgan Chase & Co. lifted their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Friday, November 29th. Piper Sandler raised their price objective on shares of Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a research report on Friday, February 28th. Macquarie initiated coverage on shares of Privia Health Group in a research report on Monday, December 16th. They set an “outperform” rating and a $25.00 price objective on the stock. Finally, Canaccord Genuity Group raised their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, February 28th. One equities research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $26.67.

Privia Health Group Trading Up 0.2 %

Shares of PRVA stock opened at $23.34 on Friday. Privia Health Group has a 12-month low of $15.92 and a 12-month high of $26.04. The firm’s 50 day moving average is $23.65 and its 200 day moving average is $21.05. The stock has a market capitalization of $2.81 billion, a P/E ratio of 233.42, a P/E/G ratio of 3.47 and a beta of 0.85.

Institutional Investors Weigh In On Privia Health Group

Hedge funds and other institutional investors have recently bought and sold shares of the company. First Horizon Advisors Inc. lifted its position in Privia Health Group by 53.8% during the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock valued at $35,000 after acquiring an additional 632 shares during the last quarter. EverSource Wealth Advisors LLC lifted its position in Privia Health Group by 7,833.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock valued at $47,000 after acquiring an additional 2,350 shares during the last quarter. Financial Management Professionals Inc. purchased a new stake in Privia Health Group during the fourth quarter valued at approximately $51,000. Quarry LP lifted its position in Privia Health Group by 344.6% during the third quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after acquiring an additional 2,533 shares during the last quarter. Finally, KBC Group NV lifted its position in Privia Health Group by 34.6% during the third quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after acquiring an additional 871 shares during the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.